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Background: Chrysin (5,7-dihydroxyflavone) inhibits platelet-derived growth factor-induced vascular smooth muscle
cell proliferation and arterial intima hyperplasia. This study aims to investigate the effects of chrysin on rat pulmonary
vascular remodeling in hypoxia-induced pulmonary hypertension (PH).
Methods: Sprague–Dawley rats were continuously exposed to 10% O2 for 4 weeks to induce PH. The effect of chrysin
(50 or 100 mg/kg/d, subcutaneous) on vascular remodeling was investigated in hypoxia-induced PH model. At the end of
the experiments, the indexes for pulmonary vascular remodeling and right ventricle hypertrophy were measured by
vascular medial wall thickness and the ratio of right ventricle to (left ventricle plus septum). The expressions of NOX4,
collagen I, and collagen III were analyzed by immunohistochemistry, real-time PCR, or western blotting. The proliferation
of cultured pulmonary artery smooth muscle cells (PASMCs) was determined by BrdU incorporation and flow cytometry.
The levels of malondialdehyde (MDA) and reactive oxygen species (ROS) were also determined by thiobarbituric acid
reactive substances assay and 2′7′-dichlorofluorescein diacetate method.
Results: Chrysin treatment for 4 weeks significantly attenuated pulmonary vascular remodeling and improved collagen
accumulation and down-regulated collagen I and collagen III expressions, accompanied by downregulation of NOX4
expression in the pulmonary artery (P = 0.012 for 50 mg/kg/d, P < 0.001 for 100 mg/kg/d) and lung tissue (P = 0.026,
P < 0.001). In vitro, chrysin (1, 10, and 100 μM) remarkably attenuated PASMC proliferation (P = 0.021 for 1 μM, P < 0.001
for 10 μM, and P < 0.001 for 100 μM), collagen I expression (P = 0.035, P < 0.001, and P < 0.001), and collagen III expression
(P = 0.027, P < 0.001, and P < 0.001) induced by hypoxia, and these inhibitory effects of chrysin were accompanied by
inhibition of NOX4 expression (P = 0.019, P < 0.001, and P < 0.001), ROS production (P = 0.038, P < 0.001, and P < 0.001),
and MDA generation (P = 0.024, P < 0.001, and P < 0.001).
Conclusions: This study demonstrated that chrysin treatment in hypoxia-induced PH in rats reversed the hypoxia-induced
(1) elevations of NOX4 expression, (2) productions of ROS and MDA, (3) proliferation of PASMC, and (4) accumulation of
collagen.
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Pulmonary hypertension (PH) is a syndrome in which
obstructed, constricted small pulmonary arteries and in-
creased pulmonary vascular resistance ultimately lead to
right ventricular hypertrophy and failure [1]. Although the
pathogenesis of PH has not been fully understood, it is
well-accepted that vascular remodeling is a hallmark of PH* Correspondence: wnmclixianwei69@163.com
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unless otherwise stated.[2,3]. The proliferation and migration of pulmonary artery
smooth muscle cells (PASMCs) and accumulation of extra-
cellular matrix (ECM) components, such as collagens, are
important processes in pulmonary vascular structural re-
modeling [4-6]. Current therapies for chronic PH-induced
vasodilation reduce pulmonary arterial resistance (e.g., ni-
tric oxide inhalation, stimulation of cGMP production by
phosphodiesterase inhibitors, endothelin receptor antago-
nists, and prostacyclin analogs) [7]. Oxidative stress is sug-
gested to contribute greatly to the development of PH and
antioxidant therapy might be a novel strategy for PH [8,9].is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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eration stimulate both systemic arterial smooth muscle
cells and PASMC proliferation [10], implicating ROS in
the vascular remodeling associated with chronic hyp-
oxia. Meanwhile, suppression of endogenous ROS pro-
duction inhibits smooth muscle cell proliferation and
promotes apoptosis [11,12]. In animal models, ROS
production has been directly linked to the vascular re-
modeling associated with chronic hypoxia-induced PH
[13,14]. Among the sources of ROS, NADPH oxidase
(NOX) can generate ROS in a highly regulated manner.
Mice maintained for 21 days under hypoxic (10% O2)
conditions had substantially increased NADPH oxidase
homologue NOX4 expression in medial PASMCs [15].
Importantly, pulmonary arteries from subjects with
idiopathic pulmonary arterial hypertension also had in-
creased expression of NOX4 [16,17]. Reduction of
NOX4 expression by rosiglitazone administration atten-
uated hypoxia-induced PH and vascular remodeling in
mice [18]. Taken together, these reports indicate that
NOX4 is an important mediator of PH caused by
hypoxia.
Chrysin (5,7-dihydroxyflavone) is a natural flavonoid
from many plant extracts, honey, and propolis [19,20],
with many biological and pharmacological activities,
such as anti-inflammatory, anticancer, antioxidant, and
antihypertensive effects [21-25]. The beneficial effects
of chrysin on the vascular endothelium was due to nitric
oxide released from the endothelium and aortic relax-
ation [26,27]. Chrysin inhibited the platelet-derived
growth factor-induced vascular smooth muscle cell pro-
liferation, and the arterial intima hyperplasia due to its
antioxidative effects [28]. This study aims to investigate
the effects of chrysin on rat pulmonary vascular remod-
eling in hypoxia-induced PH.
Methods
Materials and reagents
Chrysin (purity: >98%) was obtained from Shanghai
Pure-one Bio Technology (China; CAS: 480-40-0). A
Masson’s trichrome staining kit was purchased from
Nanjing KeyGEN Biotech (China). A BrdU cell prolifer-
ation assay kit was provided by Roche (Germany).
Dulbecco’s modified Eagle’s medium (DMEM) was pro-
vided by GIBCO (USA). Dimethyl sulfoxide (DMSO)
and diphenyleneiodonium chloride (DPI; D2926) were
purchased from Sigma (USA). Lipid peroxidation mal-
ondialdehyde (MDA) assay kit and ROS assay kit were
supplied by Beyotime Institute of Biotechnology (China).
The primers were purchased from Shanghai Sangon Bio-
logical Engineering Co. Ltd. (China). A PrimeScript reverse
transcription reagent kit and SYBR® Premix Ex Taq™ were
obtained from TaKaRa Biotechnology Co. Ltd. (China).
Anti-β-actin, anti-α-actin, anti-NOX4, anti-collagen I, andanti-collagen III primary antibodies, and horseradish
peroxidase-conjugated secondary antibodies were pur-
chased from Abcam (Hong Kong). The EasySee Western
Blot Kit was provided by Beijing TransGen Biotech
(China).
Animals
Male Sprague–Dawley rats were obtained from Nanjing
Qinglongshan Experimental Animal Company (China;
Certificate No: SCXK [jun] 2007–012). All experiments
were conducted in accordance with the US National Insti-
tutes of Health Guide for the Care and Use of Laboratory
Animals, and the experimental protocol was approved by
the Medicine Ethical Committee of Wannan Medical
College (NO.201401, date: 2014-10-13).
Animal experiments
Rats (n = 48; age: 6–8 weeks; weight: 180–220 g) were accli-
mated for 1 week, and then arbitrarily distributed into four
groups: normoxia group; hypoxia group; hypoxia plus
chrysin (50 mg/kg/d) group; and hypoxia plus chrysin
(100 mg/kg/d) group. Chrysin was initially dissolved in Tris-
buffer at pH 8.9, and the pH was then adjusted to 7.2 with
1 N HCl (Beijing institute of chemical reagents,China).
Chrysin was administered via subcutaneous injection once
daily. The rats in the normoxia group and hypoxia group
received corresponding injections of saline solution (Qilu
Pharmaceutical Co.,LTD,China). The rats in the normoxia
group were placed in normoxia (21% O2). The rats in the
hypoxia group and hypoxia plus chrysin groups were
placed in a chamber and continuously exposed to 10% O2
for 4 weeks. At the end of the experiment, the animals
were anesthetized with sodium pentobarbital (30 mg/kg,
intraperitoneal) (Shanghai solarbio Bioscience & Technol-
ogy Co., LTD, China), and the right ventricular systolic
pressure (RVSP) and mean pulmonary artery pressure
(mPAP) were monitored. After euthanasia of the animals,
the right ventricle (RV), left ventricle (LV), and interven-
tricular septum (S) were dissected from the heart and
weighed to calculate the ratio of RV to (LV + S), a key
index for evaluating hypertrophy of the RV. The freshly
isolated pulmonary arterial samples were used for mRNA
and protein expression analyses. The excised lungs were
fixed in 4% paraformaldehyde for hematoxylin-eosin and
immunohistochemical staining.
Lung tissue histology and Masson’s trichrome staining
Hematoxylin-eosin staining and Masson’s trichrome stain-
ing were performed on paraffin sections (5-μm thickness).
For quantification of the pulmonary arterial wall thickness,
the lumen diameter (or area at the basement membrane
level) and total vascular diameter (or area at the adventitial
border) in 10 muscular arteries with diameters of 100–
200 μm per lung section were outlined. The percentage of
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following formula:
WT %ð Þ ¼ areaext–areaint=areaext  100
where areaext and areaint are the areas bounded by the
external and internal elastic laminae, respectively.Figure 1 Effects of chrysin on cardiovascular remodeling in rats with hypo
(B) Mean pulmonary artery pressure (mPAP) values. (C) Ratios of right ventricle (R
(D) Statistical graph analyses of pulmonary vascular medial wall thickness (WT). (E
per group). Statistical analysis was performed with one-way ANOVA followed byMasson’s trichrome staining was used to demonstrate
collagen deposition, in which collagen fibers were stained
blue, nuclei were stained dark red/purple, and the cyto-
plasm was stained red/pink. The procedure was per-
formed according to the manufacturer’s instructions. The
collagen volume fraction (CVF) and perivascular collagen
area (PVCA) were measured and quantified using Image-
Pro plus 6.0 (Media Cybernetics, USA) to evaluate thexia-induced PH. (A) Right ventricular systolic pressure (RVSP) values.
V) weight to weight of the left ventricle (LV) plus interventricular septum (S).
) Hematoxylin-eosin staining of lung tissues. Data are means ± SD (n= 8 rats
the Newman–Student–Keuls test for multiple comparisons.
Figure 2 (See legend on next page.)
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Figure 2 Chrysin attenuated collagen expressions in pulmonary arteries from rats with hypoxia -induced PH. (A, C) The expressions of collagen I
and collagen III mRNAs were determined by real-time PCR. (B, D) The expressions of collagen I and collagen III proteins were determined by western blotting.
(E) Masson’s trichrome staining of lung tissues. (F) Collagen volume fraction (CVF) values of lung tissues. (G) Perivascular collagen area (PVCA) values. Data are
means ± SD (n= 8 rats per group). Statistical analysis was performed with one-way ANOVA followed by the Newman–Student–Keuls test for multiple
comparisons.
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interstitial space of the lung tissue was determined by cal-
culating the ratio of the collagen area to the entire area of
an individual section (CVF = blue area/(blue area + red
area) × 100%). The PVCA was analyzed by calculating the
ratio of the fibrotic area (blue area) surrounding the vessel
to the total vessel wall area.
Immunohistochemical assay
For NOX4 immunohistochemical staining in the lung, serial
sections of formalin-fixed paraffin-embedded lung tissues
were treated with 3% H2O2 for 20 min at room temperature,
followed by preincubation with 10% non-immunized serum.
The sections were then incubated with a rabbit anti-NOX4
antibody (1:100) overnight at 4°C. After unbound antibodies
were washed off, the sections were incubated with a
biotinylated goat anti-rabbit secondary antibody (1:500), and
thereafter incubated with streptavidin-horseradish peroxid-
ase. Subsequently, the bound antibodies were visualized by a
color reaction with diaminobenzidine as the substrate.
After counterstaining with hematoxylin, the sections were
dehydrated and permanently mounted. The sections were
digitized using an Olympus BX51 microscope (Olympus
Optical Co. Ltd., Japan). The digital images were processed
by the Image-Pro plus 6.0 software (USA). The positive
area and optical density (OD) of NOX4 were determined
by measuring three randomly selected microscopic fields
(25 × 10) for each slide. The immunohistochemistry index
was defined as the average integral optical density (AIOD)
(AIOD= positive area ×OD/total area).
Cell experiments
PASMCs were prepared from the pulmonary arteries of
male 10-week-old Sprague–Dawley rats by an explant
method, as described previously [27,28]. The cells were cul-
tured at 37°C under 5% CO2 in DMEM containing 20% fetal
bovine serum. PASMCs were identified by immunofluores-
cence staining with an anti-smooth muscle α-actin (1:50).
Cells between passages 3 and 8 were used for experiments.
The cells were divided into seven groups to explore the
effects of chrysin on hypoxia-induced proliferation of
PASMCs, as follows: (i) normoxia: cells were treated with
21% O2 for 48 h; (ii) hypoxia, cells were stimulated to prolif-
erate by exposure to hypoxia (3% O2, 5% CO2, 92% N2) for
48 h; (iii) +DMSO: cells were pretreated with DMSO for
1 h, and then subjected (3% O2, 5% CO2, 92% N2) for 48 h;
(iv) +DPI (25 μM): cells were pretreated with 25 μM DPI(NADPH oxidase inhibitor) for 1 h, and then subjected to
(3% O2, 5% CO2, 92% N2) for 48 h; and (v)–(vii): +chrysin
(1, 10, 100 μM): cells were pretreated with chrysin for 1 h,
and then subjected to hypoxia (3% O2, 5% CO2, 92% N2) for
48 h. Chrysin and DPI were dissolved in DMSO. Therefore,
0.1% DMSO was used as a vehicle control. In our pilot
study, we found that this concentration of DMSO had no ef-
fects on cell growth or death.
Cell proliferation assays
As described in our previous papers [29,30], cell prolifera-
tion was measured by two methods. Specifically, DNA
synthesis and the cell cycle were analyzed by BrdU mark-
ing and flow cytometry, respectively.
Intracellular ROS production
Intracellular ROS was detected by DCFH-DA. DCFH-DA
diffuses into cells and is hydrolyzed into nonfluorescent
2′,7′-dichlorofluorescein (DCFH). Produced ROS, including
H2O2, superoxide, and OH•, oxidize nonfluorescent intracel-
lular DCFH to highly fluorescent dichlorofluorescein (DCF).
In this study, cells in 96-well plates at a density of 6 × 103
cells/well were allowed to grow to the desired confluence,
and then treated with chrysin (1, 10, or 100 μM) for 1 h
prior to hypoxia. Subsequently, the cells were incubated with
DCFH-DA in the dark at 37°C for 20 min. DCF fluorescence
was detected by a fluorescence microscope and photographs
were taken. The relative levels of fluorescence were then
quantified in a fluorospectrophotometer (F4000; Hitachi
Software Engineering, Yokohama, Japan) with an excitation
wavelength of 488 nm and an emission wavelength of
525 nm.
Determination of MDA concentrations
MDA, a degradation product of lipid peroxidation, is a
class of thiobarbituric acid reactive substances (TBARS).
The MDA levels were measured using an assay for TBARS,
as described previously [31]. The protein concentrations
were determined by the bicinchoninic acid assay.
Real-time PCR analysis
Total RNA was extracted using TRIzol reagent (Invitrogen,
USA), and the isolated RNA (0.2–0.5 μg) was reverse-
transcribed by a PrimeScript reverse transcription reagent
kit. Quantitative analyses of changes in expression levels
were performed using SYBR® Premix Ex Taq™ in an ABI
7300 system (Applied Biosystems by Life Technologies,
Figure 3 (See legend on next page.)
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Figure 3 Effects of chrysin on hypoxia-induced G2/M cell cycle arrest in PASMCs. (A–G) Cell cycle distribution was monitored by flow cytometry
using a propidium iodide staining assay for the following groups: (A) Normoxia; (B) Hypoxia; (C)+DMSO; (D)+DPI (25 μM); (E)–(G) PASMCs pretreated with
chrysin (1, 10, and 100 μM) before hypoxia treatment, respectively. (H) Percentages of cells in S +G2 phase. Data are means ± SD from three independent
experiments. Statistical analysis was performed with one-way ANOVA followed by the Newman–Student–Keuls test for multiple comparisons.DPI:
diphenyleneiodonium chloride.
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incubation at 95°C for 15 s, followed by 40 cycles of
denaturation at 95°C for 5 s and annealing at 60°C
for 31 s. The following primers were used: NOX4: for-
ward, 5′-CCAGAATGAGGATCCCAGAA-3′ and re-
verse 5′- AGCAGCAGCAGCATGTAGAA-3′; collagen
I: forward, 5′-TGCTGCCTTTTCTGTTCCTT-3′ and
reverse, 5′-AAGGTGCTGGGTAGGGAAGT-3′; colla-
gen III: forward, 5′-GTCCACGAGGTGACAAAGGT-
3′ and reverse, 5′-CATCTTTTCCAGGAGGTCCA-3′;
β-actin: forward, 5′-TGTCACCAACTGGGACGATA-
3′ and reverse, 5′-ACCCTCATAGATGGGCACAG-3′.
Data analyses were performed by the comparative Ct
method by the ABI system software. GAPDH was evalu-
ated for normalization of the mRNA expression levels.
Western blot analysis
Total proteins were extracted from pulmonary arteries,
lung tissues, and PASMCs using RIPA buffer containing
0.1% PMSF (Beyotime Institute of Biotechnology, China),
and the protein concentrations were determined using the
Bradford method. Equal amounts of proteins from each
sample (50 μg) were separated by 10% SDS-PAGE and
transferred to polyvinylidene fluoride membranes. The
membranes were incubated with anti-NOX4 (1:1,000), anti-
collagen I (1:500), anti-collagen III (1:500), or anti-β-actin
(1:2000) primary antibodies overnight at 4°C, followed by
horseradish peroxidase-conjugated goat anti-rabbit (1:2000)
or rabbit anti-mouse (1:2000) secondary antibodies for 1 h.
The chemiluminescence signals were detected with an
EasySee Western Blot Kit. Densitometric analyses were
conducted with Image J 1.43 software (National Institutes
of Health, USA).
Statistical analysis
The results were presented as means ± standard deviation
(SD). Statistical analyses were performed by ANOVA by
SPSS 17.0 (IBM, USA) followed by the Newman–Student–
Keuls test for multiple comparisons. Values of P < 0.05 were
considered significant, and exact P-values were shown un-
less P < 0.001.
Results
Chrysin treatment ameliorated homodynamic and
cardiovascular remodeling
Consistent with previous studies [30], 4 weeks of ex-
posure to hypoxia induced PH in rats, as shown bysignificant elevations in RVSP and mPAP compared
with the normoxic rats (Figure 1A,B). Hypoxia also in-
duced significant hypertrophy of the RV and pulmonary
arteries, with increases in the ratio of RV/LV + S, per-
centage of WT, and proliferation of smooth muscle cells
in the vascular media of small pulmonary arteries com-
pared with the normoxia group (Figure 1C-E). All of
these effects of hypoxia were significantly alleviated by
treatment of rats with chrysin (50 or 100 mg/kg/d).
Chrysin treatment decreased collagen accumulation in
pulmonary arteries
Hypoxia markedly upregulated the expressions of colla-
gen I and collagen III mRNAs and proteins in pulmon-
ary arteries (Figure 2A-D). Hypoxia also significantly
increased the amounts of collagen accumulation in pul-
monary arteries evaluated by Masson’s trichrome stain-
ing (Figure 2E-G). All of these effects of hypoxia were
significantly decreased by treatment of rats with chrysin
(50 or 100 mg/kg/d).
Chrysin inhibited proliferation of PASMCs
Hypoxia stimulated the proliferation of PASMCs, as shown
by increases in the percentage of cells in S +G2 phase and
BrdU incorporation. Treatment with chrysin (1, 10, and
100 μM) and DPI (25 μM) significantly inhibited hypoxia-
induced proliferation of PASMCs (Figures 3 and 4A).
However, DMSO, DPI, or chrysin (100 μM) alone had no
effects on the proliferation of PASMCs under normoxia
(Figure 4B).
Chrysin suppresseed collagen I and collagen III
expressions in PASMCs
Hypoxia upregulated the expressions of collagen I and
collagen III mRNAs and proteins in PASMCs, as evalu-
ated by real-time PCR and western blotting, respectively.
Treatment with chrysin (1, 10, and 100 μM) and DPI
significantly inhibited the upregulated mRNA and pro-
tein expressions of collagen I and collagen III induced
by hypoxia (Figure 5).
Chrysin inhibited NOX4 expression
Hypoxia upregulated the expressions of NOX4 mRNA
and protein in pulmonary arteries - (Figure 6A,B) and
lung tissues- (Figure 6C-F) of rats. Chrysin inhibited the
hypoxia-induced upregulated expressions of both NOX4
mRNA and protein -. PASMCs were stimulated with
Figure 5 Effects of chrysin on hypoxia-induced expressions of collagen I and collagen III in PASMCs. (A, C) The expressions of collagen I
and collagen III mRNAs were determined by real-time PCR. (B, D) The expressions of collagen I and collagen III proteins were determined by
western blotting. Data are means ± SD from three independent experiments. Statistical analysis was performed with one-way ANOVA followed by
the Newman–Student–Keuls test for multiple comparisons. DPI: diphenyleneiodonium chloride.
Figure 4 Chrysin inhibited the proliferation of PASMCs induced by hypoxia. (A, B) Cell proliferation was measured by BrdU incorporation
assays. Data are means ± SD from three independent experiments. Statistical analysis was performed with one-way ANOVA followed by the
Newman–Student–Keuls test for multiple comparisons.
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Figure 6 Effects of chrysin on NOX4 expression in pulmonary arteries and lung tissues from rats with hypoxia-induced PH. (A, B) The
expressions of NOX4 mRNA and protein in pulmonary arteries were determined by real-time PCR and western blotting, respectively. (C, D) The
expressions of NOX4 mRNA and protein in lung tissues were determined by real-time PCR and western blotting, respectively. (E) The expression
of NOX4 in lung tissues was determined by immunohistochemical staining (arrows indicate NOX4-positive staining). (F) NOX4 average integral
optical density (AIOD) values. Data are means ± SD (n = 8 rats per group). Statistical analysis was performed with one-way ANOVA followed by the
Newman–Student–Keuls test for multiple comparisons. NOX4: NADPH oxidase 4.
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100 μM) for specified times to investigate whether chry-
sin could inhibit NOX4 expression directly. Exposure of
PASMCs to hypoxia for 48 h significantly increased the
mRNA and protein levels of NOX4, while chrysin and
DPI significantly inhibited the hypoxia-induced upregu-
lated expressions of both NOX4 mRNA and protein
(Figure 7).Effects of chrysin on ROS and MDA generation in PASMCs
Exposure of PASMCs to hypoxia for 48 h increased the
ROS and MDA productions, while chrysin or DPI sig-
nificantly reduced the increases in ROS generation and
MDA content (Figure 8).Discussion
In the present study, homodynamic analyses and histo-
logical findings demonstrated that chrysin treatment
inhibited the upregulated NOX4 and collagen expres-
sions by hypoxia both in vivo and in vitro, during the
processes of the pulmonary vascular remodeling and
process of PH in a rat model. We also found that chrysinFigure 7 Chrysin downregulated NOX4 expression induced by hypoxia in
by real-time PCR. (B) The expression of NOX4 protein was determined by weste
Statistical analysis was performed with one-way ANOVA followed by the Newm
DPI: diphenyleneiodonium chloride.significantly inhibited PASMC proliferation and ROS
and MDA generations induced by hypoxia in vitro.
Chronic hypoxia in the pulmonary vasculature is rec-
ognized as an important cause of endothelial dysfunc-
tion, PASMC proliferation, and accumulation of ECM
components, which lead to vascular remodeling [32]. In
keeping with previous study [33,34], on the 28th day of
hypoxia, the vessel wall thickness and the ratio of vessel
wall thickness to vessel diameter were significantly in-
creased concomitantly with elevated pulmonary arterial
pressure and upregulated expressions of collagen I and
III. In cultured primary PASMCs, hypoxia exposure in-
duced PASMC proliferation and collagen accumulation,
consistent with the in vivo findings in rats. In addition,
chrysin (50 or 100 mg/kg/d) significantly inhibited the
hypertrophy of pulmonary arteries and collagen I and
collagen III expressions in hypoxia-induced PH rats,
inhibited hypoxia-induced proliferation of PASMCs ac-
companied by downregulation of collagen I and collagen
III expressions. These results suggest a potential for de-
veloping chrysin as a drug to treat vascular diseases.
ROS are important regulators of vascular tone and
function [35]. In the lung, ROS are implicated in acutecultured PASMCs. (A) The expression of NOX4 mRNA was determined
rn blotting. Data are means ± SD from three independent experiments.
an–Student–Keuls test for multiple comparisons. NOX4: NADPH oxidase 4;
Figure 8 Effects of chrysin on hypoxia-induced ROS generation in cultured PASMCs. (A) Representative images of ROS fluorescence in
different groups. (B) Levels of intracellular ROS, as shown by DCF fluorescence intensities. (C) Levels of MDA. Data are means ± SD from three
independent experiments. Statistical analysis was performed with one-way ANOVA followed by the Newman–Student–Keuls test for multiple
comparisons. ROS: reactive oxygen species; MDA: malondialdehyde; DPI: diphenyleneiodonium chloride.
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hypoxia-associated increases in ROS generation may
interact with and modulate agonist-mediated pulmon-
ary artery vasoconstrictor responses. The sources of
ROS in the pulmonary vasculature are not clear. How-
ever, there is mounting evidence that NADPH oxidases
contribute to systemic vascular pathology [37,38]. These
NOX proteins have been implicated in the pathogenesis
of pulmonary vascular remodeling.NOX4-derived ROS mediates hypoxia-induced PASMC
proliferation [39], and that hypoxia-induced increases in
smooth muscle cells surrounding small pulmonary vessels
characterize hypoxia-induced pulmonary vascular alter-
ations in mice [16]. In line with these previous studies, the
present study found that hypoxia stimulated NOX4
expression, ROS and MDA productions, and PASMC pro-
liferation. In addition, chrysin significantly attenuated
hypoxia-induced NOX4 expression, and ROS and MDA
Li et al. Chinese Medicine  (2015) 10:4 Page 12 of 13productions concomitantly with decreased PASMC prolif-
eration, suggesting that inhibition of NOX4-derived ROS
production might contribute to the protective effects of
chrysin against PASMC proliferation and pulmonary vas-
cular remodeling. However, it has also been documented
that the NADPH oxidase subunit NOX2 was involved in
the development of hypoxia-induced PH [39]. The issue of
whether NOX2 was involved in the role of chrysin in the
pathogenesis of PH under our settings warrants further
investigation.
Conclusions
This study demonstrated that chrysin treatment in
hypoxia-induced PH in rats reversed the hypoxia-induced
(1) elevations of NOX4 expression, (2) productions of
ROS and MDA, (3) proliferation of PASMC, and (4) accu-
mulation of collagen.
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